Aquinox Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Aquinox Pharmaceuticals Inc
TickerNGNE
CIK #0001404644
CUSIP64135M105
SectorLife Sciences - Pharmaceutical Preparations
Address887 Great Northern Way Suite 450, Vancouver, BC V5T 4T5
Source [EDGAR]
CIK Filing 2011 - 2024
[0001404644] 10-K
[0001404644] 10-Q
[0001404644] 3
[0001404644] 4
[0001404644] 5
[0001404644] 8-K
[0001404644] D
[0001404644] SC 13D
[0001404644] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
BlackRock Inc Neurogene Inc [2024-07-08] 10.7
Janus Henderson Group PLC Neurogene Inc [2024-02-14] 6.6
Samsara Biocapital LP Neurogene Inc [2024-02-14] 0.99
EcoR1 Capital LLC Neurogene Inc [2024-02-14] 0.99
Cormorant Asset Management LP Neurogene Inc [2024-02-14] 1.21
Great Point Partners LLC Neurogene Inc [2023-12-27] 7.56
McMinn Rachel Neurogene Inc [2023-12-21] 0.9
Redmile Group LLC Neoleukin Therapeutics Inc [2023-07-27] 6.6
Pictet Asset Management Sa Neoleukin Therapeutics Inc [2023-02-03] 0.0
Lynx1 Capital Management LP Neoleukin Therapeutics Inc [2022-12-30] 5.38
Millennium Management LLC Neoleukin Therapeutics Inc [2022-07-19] 5.0
Millennium Management LLC Neoleukin Therapeutics Inc [2022-07-15] 4.97
BlackRock Inc Neoleukin Therapeutics Inc [2022-07-08] 2.1
Millennium Management LLC Neoleukin Therapeutics Inc [2022-07-07] 4.98
Pictet Asset Management Sa Neoleukin Therapeutics Inc [2022-02-10] 6.07
Redmile Group LLC Neoleukin Therapeutics Inc [2021-02-16] 0.9
ULGE UMUT Neoleukin Therapeutics Inc [2021-02-12] 6.98
Silva Manzano Daniel Adriano Neoleukin Therapeutics Inc [2021-02-12] 6.96
BlackRock Inc Neoleukin Therapeutics Inc [2021-02-02] 6.4
Silva Manzano Daniel Adriano Neoleukin Therapeutics Inc [2020-02-13] 8.2
ULGE UMUT Neoleukin Therapeutics Inc [2020-02-13] 8.2
EcoR1 Capital LLC Neoleukin Therapeutics Inc [2019-12-27] 8.1
Drachman Jonathan G Neoleukin Therapeutics Inc [2019-12-27] 5.8
EcoR1 Capital LLC Aquinox Pharmaceuticals Inc [2018-07-16] 7.5
Price T Rowe Associates Inc /MD/ Aquinox Pharmaceuticals Inc [2016-10-11] 14.4
Ventures West 8 Limited Partnership Aquinox Pharmaceuticals Inc [2016-02-16] 5.93
BlackRock Inc Aquinox Pharmaceuticals Inc [2016-01-28] 5.3
Visium Asset Management LP Aquinox Pharmaceuticals Inc [2015-09-21] 8.6
RA Capital Management LLC Aquinox Pharmaceuticals Inc [2015-08-24] 0.6
Baker Bros Advisors LP Aquinox Pharmaceuticals Inc [2015-08-10] 39.8
Augment Investments Ltd Aquinox Pharmaceuticals Inc [2015-02-12] 5.3
Ventures West 8 Limited Partnership Aquinox Pharmaceuticals Inc [2015-02-11] 14.1
Franklin Resources Inc Aquinox Pharmaceuticals Inc [2015-02-09] 5.5
Johnson & Johnson Aquinox Pharmaceuticals Inc [2015-02-06] 15.1
Baker Bros Advisors LP Aquinox Pharmaceuticals Inc [2014-04-10] 12.1
Pfizer Inc Aquinox Pharmaceuticals Inc [2014-03-21] 9.0
Form 3/4/5 Filer 2011 - 2024
Woods Robert Keith
Neurogene Inc.
Freedland Cory S.
Noonberg Sarah B.
Baffi Robert
Palekar Rohan
Cobb Stuart
McMinn Rachel
Cvijic Christine Mikail
Jordan Julie
667 LP
Baker Julian
Baker Brothers Life Sciences LP
Baker Bros. Advisors (GP) LLC
Baker Bros Advisors LP
Baker Felix
Smith Sean Michael
Lavelle Erin
Babler Martin
Simpson Todd E
Patel Priti
Walkey Carl
Cochener Donna
Drachman Jonathan G
Ho Robert
Vance Holly
Williams Lewis T
Lavelle Erin M.
Nolan Sean P.
Green Jeremy
Redmile Group, LLC
Boyd Meta Cantey
Main David
Alam Kamran
MacKenzie Lloyd
McCloskey Shelley
Levitt Daniel J
Bridger Gary
Pelzer Robert
Jenkins Abigail
Troupin Barbara
Levy Richard S
Mitchell David Chilton
Shrewsbury Stephen B
Pfizer Inc
Johnson & Johnson
Johnson & Johnson Innovation - JJDC, Inc.
Ventures West 8 Limited Partnership
Jones Elaine V
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock Finance, Inc. [2024-06-30] SOLE 1,385,699.0 1,394,714.0
EcoR1 Capital LLC [2024-06-30] SOLE 1,271,342.0 1,271,342.0
Samsara Biocapital LLC [2024-06-30] SOLE 1,267,790.0 1,267,790.0
RTW Investments LP [2024-06-30] SOLE 1,070,565.0 1,070,565.0
Redmile Group LLC [2024-06-30] SOLE 1,013,663.0 1,013,663.0
Great Point Partners LLC [2024-06-30] DFND 0.0 1,004,291.0
Janus Henderson Group PLC [2024-06-30] DFND 0.0 834,791.0
Avidity Partners Management LP [2024-06-30] SOLE 727,537.0 727,537.0
Vanguard Group Inc [2024-06-30] SOLE 0.0 549,410.0
Casdin Capital LLC [2024-06-30] SOLE 524,616.0 524,616.0
Baker Bros Advisors LP [2024-06-30] SOLE 456,015.0 456,015.0
ArrowMark Colorado Holdings LLC [2024-06-30] SOLE 386,465.0 386,465.0
Morgan Stanley [2024-06-30] DFND 379,896.0 382,668.0
Deutsche Bank AG [2024-06-30] DFND 60,138.0 332,284.0
Geode Capital Management LLC [2024-06-30] DFND 222,062.0 222,062.0
State Street Corp [2024-06-30] DFND 199,590.0 209,853.0
Commodore Capital LP [2024-06-30] SOLE 200,000.0 200,000.0
Adage Capital Partners GP LLC [2024-06-30] SOLE 161,900.0 161,900.0
Nantahala Capital Management LLC [2024-06-30] SOLE 144,558.0 144,558.0
Invesco Ltd. [2024-06-30] DFND 0.0 133,694.0
Cormorant Asset Management LP [2024-06-30] DFND 107,344.0 107,344.0
Driehaus Capital Management LLC [2024-06-30] SOLE 102,187.0 102,187.0
Walleye Capital LLC [2024-06-30] SOLE 92,500.0 92,500.0
Stempoint Capital LP [2024-06-30] SOLE 78,601.0 78,601.0
FMR LLC [2024-06-30] DFND 72,286.0 72,286.0
Integral Health Asset Management LLC [2024-06-30] SOLE 70,000.0 70,000.0
Ghost Tree Capital LLC [2024-06-30] SOLE 70,000.0 70,000.0
Renaissance Technologies LLC [2024-06-30] SOLE 52,807.0 52,807.0
Marshall Wace LLP [2024-06-30] OTR 0.0 41,447.0
Susquehanna International Group LLP [2024-06-30] DFND 40,765.0 40,765.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com